Angel One - Share Market Trading and Stock Broking
Skip to main content

Live Zymeworks Inc. Share Price Chart

O H L

Zymeworks Inc. Performance Overview

Days Range
▼
$25.53Low
$26.24High

Markets Today

Previous Close$25.26
Open$25.53
Volume486,977
Day's Range$25.53 - $26.24
52W Range$16.00 - $31.34
Market Cap$1.81 B

Historical Performance

1M Returns-2.44
3M Returns-0.35
6M Returns-2.01
1Y Returns+42.80
5Y Returns+0.51
10Y ReturnsNA

Zymeworks Inc. Fundamentals

Market Cap$1.81 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$105.97 M
ROE TTM-0.27
EPS TTM$-2.01
Quarterly Earnings Growth YOYN/A
PB Ratio22.62
EBITDA$-84.82 M
Profit Margin-76.56
Market Cap$1.81 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$105.97 M
ROE TTM-0.27
EPS TTM$-2.01
Quarterly Earnings Growth YOYN/A
PB Ratio22.62
EBITDA$-84.82 M
Profit Margin-76.56

Zymeworks Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$27.11 M$48.73 M$27.61 M$2.52 M$2.41 M$4.59 M
Gross Profit +$27.11 M$48.73 M$27.61 M$2.52 M$2.41 M$4.59 M
Operating Income -$25.61 M-$674.00 K-$22.11 M-$44.15 M-$47.12 M-$42.18 M
EBITDA -$23.02 M$1.82 M-$20.56 M-$43.07 M-$45.98 M-$41.05 M
Interest Expense $3.42 M$0$0$0$645.00 K-$6.59 M
Depreciation $2.60 M$2.49 M$1.55 M$1.08 M$1.14 M$1.13 M
Income Before Tax -$22.14 M$2.13 M-$18.27 M-$41.48 M-$46.35 M-$45.29 M
Income Tax Expense $496.00 K-$186.00 K$1.34 M-$270.00 K-$2.19 M-$273.00 K
Net Income +-$22.64 M$2.32 M-$19.60 M-$41.21 M-$44.16 M-$45.02 M
Net Profit Margin -83.5%4.76%-70.99%-1638.53%-1833.97%-980.81%

Zymeworks Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $1.02 B$1.07 B$1.09 B$1.11 B$1.13 B$1.13 B
Reserve & Surplus -$859.38 M-$856.99 M-$892.52 M-$959.24 M-$1.08 B-$1.18 B
Non-Current Liabilities $35.45 M$35.38 M$35.16 M$35.71 M$278.98 M$269.35 M
Current Liabilities $65.10 M$38.50 M$42.04 M$42.32 M$35.65 M$47.24 M
Total Liabilities $100.56 M$73.88 M$77.20 M$78.03 M$314.63 M$316.60 M
Fixed Assets $20.05 M$18.36 M$17.22 M$16.85 M$16.03 M$14.95 M
Current Assets $306.47 M$296.13 M$291.71 M$248.77 M$385.68 M$298.39 M
Total Assets $425.52 M$408.38 M$397.27 M$346.53 M$478.21 M$396.96 M

Zymeworks Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$22.64 M$2.32 M-$19.60 M-$41.21 M-$44.16 M-$45.02 M
Operating Cash Flow -$3.41 M$12.07 M-$31.41 M-$10.26 M-$45.72 M-$31.95 M
Investing Cash Flow $12.18 M$8.74 M$368.00 K$5.37 M$69.96 M$17.07 M
Financing Cash Flow $1.32 M$1.32 M-$2.45 M-$18.74 M$178.79 M-$50.02 M
Change in Cash $10.10 M$22.05 M-$33.42 M-$23.68 M$203.13 M-$64.87 M

Zymeworks Inc. Return Calculator

The Zymeworks Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$8,963
Invested Amount$10,000
Est. Returns$-1,037
Invest in USA Stock Today

About Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

FAQs

Zymeworks Inc. (ZYME) share price as of October 10, 2026 is $23.00. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Zymeworks Inc. (ZYME) Share by opening an international trading account with Angel One.
Purchasing Zymeworks Inc. (ZYME) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Zymeworks Inc. (ZYME) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Zymeworks Inc. (ZYME) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Zymeworks Inc. on October 10, 2026, is $1.81 B.
Zymeworks Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Zymeworks Inc. (ZYME) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL